AKEBIA THERAPEUTICS, INC. Lessor, Operating Lease, Payment to be Received, Year Three
AKEBIA THERAPEUTICS, INC. (AKBA) had Lessor, Operating Lease, Payment to be Received, Year Three of $0 as of 2022-12-31, per its 10-K/A filed 2023-08-28.
Discontinued › Notes › Leases › Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity
us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears · last filed 2023-08-28
- 2022-12-31: Lessor, Operating Lease, Payment to be Received, Year Three $0.00.
- 2022-09-30: Lessor, Operating Lease, Payment to be Received, Year Three $0.00.
- 2022-06-30: Lessor, Operating Lease, Payment to be Received, Year Three $0.00.
- 2022-03-31: Lessor, Operating Lease, Payment to be Received, Year Three $0.00.
| Period end | Lessor, Operating Lease, Payment to be Received, Year Three |
|---|---|
| 2022-12-31 | $0.00 10-K/A · filed 2023-08-28 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-12-31 | $307.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $307.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $307.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.82M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $1.82M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |